Orphazyme elects new board member
Andrew Mercieca has been formally appointed to the board of biotech company Orphazyme at an extraordinary general meeting.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
At an extraordinary general meeting on Tuesday, biotech firm Orphazyme elected a new board member, Andrew Mercieca.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme makes changes to board of directors
For subscribers
Orphazyme gets investor backing for fundraising round
For subscribers
Orphazyme plans to resubmit FDA application in H2
For subscribers
